Development of immediate‐release formulation with reliable absorption of rivaroxaban in various meal regimes
Abstract The bioavailability of rivaroxaban at the higher doses (15 and 20 mg) is considerably reduced when the drug is administered on an empty stomach. This can lead to inadequate anticoagulant effect, and therefore, it is recommended to use the higher doses at fed state. However, proper posology...
שמור ב:
| Principais autores: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2024-05-01
|
| סדרה: | Clinical and Translational Science |
| גישה מקוונת: | https://doi.org/10.1111/cts.13820 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|